Form 4: AbCellera Biologics Director Reports Stock Transaction
Insider Transaction (Form 4)
Michael R Hayden, a Director of AbCellera Biologics Inc., reported a transaction in 50,000 shares of common stock on August 11, 2026.
Summary
- Bona fide gift: disposed of 50,000 Common Shares on August 11, 2026; holds 1,273,397 after (Indirect).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Michael R Hayden — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-11 | Bona fide gift | Common Shares | 50,000 | — | — | 1,273,397 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-11 | Bona fide gift (50,000 shares) |
Keywords
insider transaction, Form 4, ABCL, AbCellera Biologics Inc., neutral, Michael R Hayden
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.